ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liposome Development Service Market Research Report 2026
Published Date: 2026-03-27
|
Report Code: QYRE-Auto-36V11246
Home | Market Reports | Business & Industrial| Business Services
Global Liposome Development Service Market Research Report 2022
BUY CHAPTERS

Global Liposome Development Service Market Research Report 2026

Code: QYRE-Auto-36V11246
Report
2026-03-27
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Creative-Biolabs
Creative Biostructure
Evonik
PlantaCorp
CD Bioparticles
Exelead
T&T Scientific
FormuMax Scientific
Precision Nanosystems
Merck KGaA
Genevant Sciences
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
T&T Scientific

Liposome Development Service Market Size

The global Liposome Development Service market was valued at US$ 1306 million in 2025 and is anticipated to reach US$ 2230 million by 2032, at a CAGR of 8.1% from 2026 to 2032.

Liposome Development Service Market

Liposome Development Service Market

Liposomes are a type of nano-sized phospholipid bubbles, which have attracted much attention as potential drug carriers. Liposomes are highly biocompatible and easy to control in vivo and can be loaded with a broad variety of drugs, DNA, and diagnostic agents. To date, a variety of liposomal drugs are under development and some of them are already approved for clinical use.
Market Driver
The liposome development service market is driven by the growing demand for advanced drug delivery systems that enhance the bioavailability, efficacy, and safety of therapeutics. Liposomes, being biocompatible and capable of targeted drug delivery, are increasingly used in the development of treatments for cancer, infectious diseases, and vaccines. Additionally, the rise in biologics and personalized medicine, coupled with advancements in nanotechnology, supports the growth of the liposome development service market.
Market Challenge
Despite its potential, the liposome development service market faces challenges such as high production costs and complex manufacturing processes that require specialized expertise and facilities. Regulatory hurdles in the approval of liposome-based therapies and the potential for stability issues during storage and transportation further constrain the market's growth. These factors create barriers, particularly for smaller companies with limited resources.
Global key players of liposome development service include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, etc. The top two players hold a share over 52%. North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately. In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.
This report delivers a comprehensive overview of the global Liposome Development Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Liposome Development Service. The Liposome Development Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Liposome Development Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Liposome Development Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Liposome Development Service Market Report

Report Metric Details
Report Name Liposome Development Service Market
Accounted market size in 2025 US$ 1306 million
Forecasted market size in 2032 US$ 2230 million
CAGR 8.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Liposomes
  • Lipid Nanoparticles
Segment by Application
  • Preclinical
  • Clinical
  • Commercial
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, Creative Biostructure, T&T Scientific, FormuMax Scientific, PlantaCorp, CD Bioparticles
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Liposome Development Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Liposome Development Service Market growing?

Ans: The Liposome Development Service Market witnessing a CAGR of 8.1% during the forecast period 2026-2032.

What is the Liposome Development Service Market size in 2032?

Ans: The Liposome Development Service Market size in 2032 will be US$ 2230 million.

What is the market share of major companies in Liposome Development Service Market?

Ans: The top two players hold a share over 52%.

What is the Liposome Development Service Market share by region?

Ans: North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately.

What is the Liposome Development Service Market share by type?

Ans: In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.

Who are the main players in the Liposome Development Service Market report?

Ans: The main players in the Liposome Development Service Market are Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, Creative Biostructure, T&T Scientific, FormuMax Scientific, PlantaCorp, CD Bioparticles

What are the Application segmentation covered in the Liposome Development Service Market report?

Ans: The Applications covered in the Liposome Development Service Market report are Preclinical, Clinical, Commercial

What are the Type segmentation covered in the Liposome Development Service Market report?

Ans: The Types covered in the Liposome Development Service Market report are Liposomes, Lipid Nanoparticles

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposome Development Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Liposome Development Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Development Service Market Perspective (2021–2032)
2.2 Global Liposome Development Service Growth Trends by Region
2.2.1 Global Liposome Development Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Liposome Development Service Historic Market Size by Region (2021–2026)
2.2.3 Liposome Development Service Forecasted Market Size by Region (2027–2032)
2.3 Liposome Development Service Market Dynamics
2.3.1 Liposome Development Service Industry Trends
2.3.2 Liposome Development Service Market Drivers
2.3.3 Liposome Development Service Market Challenges
2.3.4 Liposome Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposome Development Service Players by Revenue
3.1.1 Global Top Liposome Development Service Players by Revenue (2021–2026)
3.1.2 Global Liposome Development Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Liposome Development Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Liposome Development Service Revenue
3.4 Global Liposome Development Service Market Concentration Ratio
3.4.1 Global Liposome Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposome Development Service Revenue in 2025
3.5 Global Key Players of Liposome Development Service Head Offices and Areas Served
3.6 Global Key Players of Liposome Development Service, Products and Applications
3.7 Global Key Players of Liposome Development Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Liposome Development Service Breakdown Data by Type
4.1 Global Liposome Development Service Historic Market Size by Type (2021–2026)
4.2 Global Liposome Development Service Forecasted Market Size by Type (2027–2032)
5 Liposome Development Service Breakdown Data by Application
5.1 Global Liposome Development Service Historic Market Size by Application (2021–2026)
5.2 Global Liposome Development Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Liposome Development Service Market Size (2021–2032)
6.2 North America Liposome Development Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Liposome Development Service Market Size by Country (2021–2026)
6.4 North America Liposome Development Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposome Development Service Market Size (2021–2032)
7.2 Europe Liposome Development Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Liposome Development Service Market Size by Country (2021–2026)
7.4 Europe Liposome Development Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Liposome Development Service Market Size (2021–2032)
8.2 Asia-Pacific Liposome Development Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Liposome Development Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Liposome Development Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Liposome Development Service Market Size (2021–2032)
9.2 Latin America Liposome Development Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Liposome Development Service Market Size by Country (2021–2026)
9.4 Latin America Liposome Development Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposome Development Service Market Size (2021–2032)
10.2 Middle East & Africa Liposome Development Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Liposome Development Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Liposome Development Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Details
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Liposome Development Service Introduction
11.1.4 Precision NanoSystems Revenue in Liposome Development Service Business (2021–2026)
11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Liposome Development Service Introduction
11.2.4 Evonik Revenue in Liposome Development Service Business (2021–2026)
11.2.5 Evonik Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Liposome Development Service Introduction
11.3.4 Merck KGaA Revenue in Liposome Development Service Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Details
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Liposome Development Service Introduction
11.4.4 Genevant Sciences Revenue in Liposome Development Service Business (2021–2026)
11.4.5 Genevant Sciences Recent Development
11.5 Exelead
11.5.1 Exelead Company Details
11.5.2 Exelead Business Overview
11.5.3 Exelead Liposome Development Service Introduction
11.5.4 Exelead Revenue in Liposome Development Service Business (2021–2026)
11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Details
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Liposome Development Service Introduction
11.6.4 Avanti Polar Lipids Revenue in Liposome Development Service Business (2021–2026)
11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Details
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Liposome Development Service Introduction
11.7.4 Nippon Fine Chemical Revenue in Liposome Development Service Business (2021–2026)
11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
11.8.1 Lipoid Company Details
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Liposome Development Service Introduction
11.8.4 Lipoid Revenue in Liposome Development Service Business (2021–2026)
11.8.5 Lipoid Recent Development
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Details
11.9.2 Polymun Scientific Business Overview
11.9.3 Polymun Scientific Liposome Development Service Introduction
11.9.4 Polymun Scientific Revenue in Liposome Development Service Business (2021–2026)
11.9.5 Polymun Scientific Recent Development
11.10 Corden Pharma
11.10.1 Corden Pharma Company Details
11.10.2 Corden Pharma Business Overview
11.10.3 Corden Pharma Liposome Development Service Introduction
11.10.4 Corden Pharma Revenue in Liposome Development Service Business (2021–2026)
11.10.5 Corden Pharma Recent Development
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Details
11.11.2 Acuitas Therapeutics Business Overview
11.11.3 Acuitas Therapeutics Liposome Development Service Introduction
11.11.4 Acuitas Therapeutics Revenue in Liposome Development Service Business (2021–2026)
11.11.5 Acuitas Therapeutics Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Liposome Development Service Introduction
11.12.4 Creative Biolabs Revenue in Liposome Development Service Business (2021–2026)
11.12.5 Creative Biolabs Recent Development
11.13 Creative Biostructure
11.13.1 Creative Biostructure Company Details
11.13.2 Creative Biostructure Business Overview
11.13.3 Creative Biostructure Liposome Development Service Introduction
11.13.4 Creative Biostructure Revenue in Liposome Development Service Business (2021–2026)
11.13.5 Creative Biostructure Recent Development
11.14 T&T Scientific
11.14.1 T&T Scientific Company Details
11.14.2 T&T Scientific Business Overview
11.14.3 T&T Scientific Liposome Development Service Introduction
11.14.4 T&T Scientific Revenue in Liposome Development Service Business (2021–2026)
11.14.5 T&T Scientific Recent Development
11.15 FormuMax Scientific
11.15.1 FormuMax Scientific Company Details
11.15.2 FormuMax Scientific Business Overview
11.15.3 FormuMax Scientific Liposome Development Service Introduction
11.15.4 FormuMax Scientific Revenue in Liposome Development Service Business (2021–2026)
11.15.5 FormuMax Scientific Recent Development
11.16 PlantaCorp
11.16.1 PlantaCorp Company Details
11.16.2 PlantaCorp Business Overview
11.16.3 PlantaCorp Liposome Development Service Introduction
11.16.4 PlantaCorp Revenue in Liposome Development Service Business (2021–2026)
11.16.5 PlantaCorp Recent Development
11.17 CD Bioparticles
11.17.1 CD Bioparticles Company Details
11.17.2 CD Bioparticles Business Overview
11.17.3 CD Bioparticles Liposome Development Service Introduction
11.17.4 CD Bioparticles Revenue in Liposome Development Service Business (2021–2026)
11.17.5 CD Bioparticles Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Creative-Biolabs
Creative Biostructure
Evonik
PlantaCorp
CD Bioparticles
Exelead
T&T Scientific
FormuMax Scientific
Precision Nanosystems
Merck KGaA
Genevant Sciences
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
T&T Scientific
List of Tables
 Table 1. Global Liposome Development Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Liposomes
 Table 3. Key Players of Lipid Nanoparticles
 Table 4. Global Liposome Development Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Liposome Development Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Liposome Development Service Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Liposome Development Service Market Share by Region (2021–2026)
 Table 8. Global Liposome Development Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Liposome Development Service Market Share by Region (2027–2032)
 Table 10. Liposome Development Service Market Trends
 Table 11. Liposome Development Service Market Drivers
 Table 12. Liposome Development Service Market Challenges
 Table 13. Liposome Development Service Market Restraints
 Table 14. Global Liposome Development Service Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Liposome Development Service Market Share by Players (2021–2026)
 Table 16. Global Top Liposome Development Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Liposome Development Service Revenue, 2025
 Table 17. Ranking of Global Top Liposome Development Service Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Liposome Development Service Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Liposome Development Service, Headquarters and Area Served
 Table 20. Global Key Players of Liposome Development Service, Products and Applications
 Table 21. Global Key Players of Liposome Development Service, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Liposome Development Service Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Liposome Development Service Revenue Market Share by Type (2021–2026)
 Table 25. Global Liposome Development Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Liposome Development Service Revenue Market Share by Type (2027–2032)
 Table 27. Global Liposome Development Service Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Liposome Development Service Revenue Market Share by Application (2021–2026)
 Table 29. Global Liposome Development Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Liposome Development Service Revenue Market Share by Application (2027–2032)
 Table 31. North America Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Liposome Development Service Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Liposome Development Service Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Liposome Development Service Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Liposome Development Service Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Liposome Development Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Liposome Development Service Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Liposome Development Service Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Liposome Development Service Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Liposome Development Service Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Liposome Development Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Liposome Development Service Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Liposome Development Service Market Size by Country (US$ Million), 2027–2032
 Table 46. Precision NanoSystems Company Details
 Table 47. Precision NanoSystems Business Overview
 Table 48. Precision NanoSystems Liposome Development Service Product
 Table 49. Precision NanoSystems Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 50. Precision NanoSystems Recent Development
 Table 51. Evonik Company Details
 Table 52. Evonik Business Overview
 Table 53. Evonik Liposome Development Service Product
 Table 54. Evonik Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 55. Evonik Recent Development
 Table 56. Merck KGaA Company Details
 Table 57. Merck KGaA Business Overview
 Table 58. Merck KGaA Liposome Development Service Product
 Table 59. Merck KGaA Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 60. Merck KGaA Recent Development
 Table 61. Genevant Sciences Company Details
 Table 62. Genevant Sciences Business Overview
 Table 63. Genevant Sciences Liposome Development Service Product
 Table 64. Genevant Sciences Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 65. Genevant Sciences Recent Development
 Table 66. Exelead Company Details
 Table 67. Exelead Business Overview
 Table 68. Exelead Liposome Development Service Product
 Table 69. Exelead Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 70. Exelead Recent Development
 Table 71. Avanti Polar Lipids Company Details
 Table 72. Avanti Polar Lipids Business Overview
 Table 73. Avanti Polar Lipids Liposome Development Service Product
 Table 74. Avanti Polar Lipids Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 75. Avanti Polar Lipids Recent Development
 Table 76. Nippon Fine Chemical Company Details
 Table 77. Nippon Fine Chemical Business Overview
 Table 78. Nippon Fine Chemical Liposome Development Service Product
 Table 79. Nippon Fine Chemical Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 80. Nippon Fine Chemical Recent Development
 Table 81. Lipoid Company Details
 Table 82. Lipoid Business Overview
 Table 83. Lipoid Liposome Development Service Product
 Table 84. Lipoid Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 85. Lipoid Recent Development
 Table 86. Polymun Scientific Company Details
 Table 87. Polymun Scientific Business Overview
 Table 88. Polymun Scientific Liposome Development Service Product
 Table 89. Polymun Scientific Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 90. Polymun Scientific Recent Development
 Table 91. Corden Pharma Company Details
 Table 92. Corden Pharma Business Overview
 Table 93. Corden Pharma Liposome Development Service Product
 Table 94. Corden Pharma Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 95. Corden Pharma Recent Development
 Table 96. Acuitas Therapeutics Company Details
 Table 97. Acuitas Therapeutics Business Overview
 Table 98. Acuitas Therapeutics Liposome Development Service Product
 Table 99. Acuitas Therapeutics Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 100. Acuitas Therapeutics Recent Development
 Table 101. Creative Biolabs Company Details
 Table 102. Creative Biolabs Business Overview
 Table 103. Creative Biolabs Liposome Development Service Product
 Table 104. Creative Biolabs Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 105. Creative Biolabs Recent Development
 Table 106. Creative Biostructure Company Details
 Table 107. Creative Biostructure Business Overview
 Table 108. Creative Biostructure Liposome Development Service Product
 Table 109. Creative Biostructure Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 110. Creative Biostructure Recent Development
 Table 111. T&T Scientific Company Details
 Table 112. T&T Scientific Business Overview
 Table 113. T&T Scientific Liposome Development Service Product
 Table 114. T&T Scientific Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 115. T&T Scientific Recent Development
 Table 116. FormuMax Scientific Company Details
 Table 117. FormuMax Scientific Business Overview
 Table 118. FormuMax Scientific Liposome Development Service Product
 Table 119. FormuMax Scientific Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 120. FormuMax Scientific Recent Development
 Table 121. PlantaCorp Company Details
 Table 122. PlantaCorp Business Overview
 Table 123. PlantaCorp Liposome Development Service Product
 Table 124. PlantaCorp Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 125. PlantaCorp Recent Development
 Table 126. CD Bioparticles Company Details
 Table 127. CD Bioparticles Business Overview
 Table 128. CD Bioparticles Liposome Development Service Product
 Table 129. CD Bioparticles Revenue in Liposome Development Service Business (US$ Million), 2021–2026
 Table 130. CD Bioparticles Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Liposome Development Service Picture
 Figure 2. Global Liposome Development Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Liposome Development Service Market Share by Type: 2025 vs 2032
 Figure 4. Liposomes Features
 Figure 5. Lipid Nanoparticles Features
 Figure 6. Global Liposome Development Service Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Liposome Development Service Market Share by Application: 2025 vs 2032
 Figure 8. Preclinical Case Studies
 Figure 9. Clinical Case Studies
 Figure 10. Commercial Case Studies
 Figure 11. Liposome Development Service Report Years Considered
 Figure 12. Global Liposome Development Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Liposome Development Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Liposome Development Service Market Share by Region: 2025 vs 2032
 Figure 15. Global Liposome Development Service Market Share by Players in 2025
 Figure 16. Global Liposome Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Liposome Development Service Revenue in 2025
 Figure 18. North America Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Liposome Development Service Market Share by Country (2021–2032)
 Figure 20. United States Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Liposome Development Service Market Share by Country (2021–2032)
 Figure 24. Germany Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Liposome Development Service Market Share by Region (2021–2032)
 Figure 32. China Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Liposome Development Service Market Share by Country (2021–2032)
 Figure 40. Mexico Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Liposome Development Service Market Share by Country (2021–2032)
 Figure 44. Israel Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Liposome Development Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Precision NanoSystems Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 48. Evonik Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 49. Merck KGaA Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 50. Genevant Sciences Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 51. Exelead Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 52. Avanti Polar Lipids Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 53. Nippon Fine Chemical Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 54. Lipoid Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 55. Polymun Scientific Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 56. Corden Pharma Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 57. Acuitas Therapeutics Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 58. Creative Biolabs Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 59. Creative Biostructure Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 60. T&T Scientific Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 61. FormuMax Scientific Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 62. PlantaCorp Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 63. CD Bioparticles Revenue Growth Rate in Liposome Development Service Business (2021–2026)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Liposomal Market Insights Forecast to 2030
Global liposomes in Skin Care Market Research Report 2025
Global Microsphere Liposomes Market Research Report 2024
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
Global Liposome for Cosmetic Ingredients Market Research Report 2025
Global Liposome Drug Delivery Market Insights Forecast to 2030
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Contract Manufacturing Market Research Report 2024
Global Liposome Development and Manufacturing Service Market Research Report 2025
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes for Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Microsphere Market Research Report 2024
Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lipid Customization Service Market Research Report 2024
Liposome and Lipid Nanoparticle FDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions